How to choose a contract pharmaceutical manufacturer in India

A practical B2B buyer's guide to certifications, dosage-form capability, documentation discipline, capacity, and innovation.

India's pharmaceutical contract manufacturing sector offers extensive formulation expertise and production capacity. The number of available partners, however, makes careful selection essential.

This guide sets out the criteria that distinguish a reliable contract manufacturer from one that may create compliance, quality, or supply-chain problems later.

Start with regulatory certification

The first filter is non-negotiable: confirm that each manufacturer holds current certifications appropriate to your target markets. For export markets, WHO-GMP is a widely recognised benchmark, while individual markets may require additional approvals.

Request current certificates and verify issue and expiry dates. The manufacturer's ability to explain its quality systems matters as much as displaying certification logos.

Assess dosage-form capability honestly

Not all facilities manufacture all dosage forms. Match your requirements precisely to the manufacturer's demonstrated capability.

  • Is the facility beta lactam or non-beta lactam?
  • Do available batch sizes align with expected volumes?
  • Does the facility have experience in the relevant therapeutic category?
  • Are sustained-release or modified-release formulations within its capability?

Evaluate documentation discipline

In contract pharmaceutical manufacturing, documentation is inseparable from the product. Review batch manufacturing records, standard operating procedures, validation reports, and deviation handling. Weak documentation creates regulatory risk for the brand owner and partner.

Understand capacity and lead times realistically

Before committing, understand current utilisation, typical production queues for the required dosage form, and how priorities are managed during peak demand. Ask how disruptions are communicated and resolved.

Consider formulation-development capability

If your pipeline includes new formulations, modified-release products, or product transfer, active research and development capability adds meaningful value. Facilities with formulation scientists, internally developed products, and regulatory-submission experience can support evolving portfolios.

Why location within India matters

Uttarakhand has developed into an important pharmaceutical manufacturing region with a skilled workforce, supply-chain infrastructure, and regulatory familiarity concentrated around Dehradun and Haridwar.

Swift Life Sciences as a manufacturing partner

Swift Life Sciences operates a dedicated non-beta lactam composite manufacturing facility at Rampur, Dehradun, producing tablets, hard gelatin capsules, oral liquids, and topical formulations for own-brand and selected partner-brand supply.

For companies evaluating product transfer, selected brand work, or catalogue supply, Swift welcomes verified business enquiries.

Start a qualified manufacturing discussion

Review Swift's product capabilities, explore the facility and certifications, and share your requirements through the business enquiry form.